Cargando…
GM‐CSF and IL‐7 fusion cytokine engineered tumor vaccine generates long‐term Th‐17 memory cells and increases overall survival in aged syngeneic mouse models of glioblastoma
Age‐related immune dysfunctions, such as decreased T‐cell output, are closely related to pathologies like cancers and lack of vaccine efficacy among the elderly. Engineered fusokine, GIFT‐7, a fusion of interleukin 7 (IL‐7) and GM‐CSF, can reverse aging‐related lymphoid organ atrophy. We generated a...
Autores principales: | Shireman, Jack M., Gonugunta, Nikita, Zhao, Lei, Pattnaik, Akshita, Distler, Emily, Her, Skyler, Wang, Xiaohu, Das, Rahul, Galipeau, Jaques, Dey, Mahua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352573/ https://www.ncbi.nlm.nih.gov/pubmed/37165998 http://dx.doi.org/10.1111/acel.13864 |
Ejemplares similares
-
Sexual dimorphism of the immune system predicts clinical outcomes in glioblastoma immunotherapy: A systematic review and meta-analysis
por: Shireman, Jack M, et al.
Publicado: (2022) -
Reduced expression of FRG1 facilitates breast cancer progression via GM-CSF/MEK-ERK axis by abating FRG1 mediated transcriptional repression of GM-CSF
por: Mukherjee, Bratati, et al.
Publicado: (2022) -
GM-CSF in inflammation
por: Hamilton, John A.
Publicado: (2019) -
Use of syngeneic cells expressing membrane-bound GM-CSF as an adjuvant to induce antibodies against native multi-pass transmembrane protein
por: Huang, Chien-Chiao, et al.
Publicado: (2019) -
G-CSF and GM-CSF in clinical trials.
por: Antman, K. H.
Publicado: (1990)